118 related articles for article (PubMed ID: 10656388)
1. In vitro efficacy of a novel chemoradiopotentiator--taxoltere metro.
Yang LX; Wang HJ; Holton RA
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):159-63. PubMed ID: 10656388
[TBL] [Abstract][Full Text] [Related]
2. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
Hill BT; Whelan RD; Shellard SA; McClean S; Hosking LK
Invest New Drugs; 1994; 12(3):169-82. PubMed ID: 7896535
[TBL] [Abstract][Full Text] [Related]
3. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
Hennequin C; Giocanti N; Favaudon V
Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
[TBL] [Abstract][Full Text] [Related]
4. Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer.
Creane M; Seymour CB; Colucci S; Mothersill C
Int J Radiat Biol; 1999 Jun; 75(6):731-7. PubMed ID: 10405003
[TBL] [Abstract][Full Text] [Related]
5. Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure.
Makarovskiy AN; Siryaporn E; Hixson DC; Akerley W
Cell Mol Life Sci; 2002 Jul; 59(7):1198-211. PubMed ID: 12222966
[TBL] [Abstract][Full Text] [Related]
6. Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro.
Skvortsova I; Skvortsov S; Haidenberger A; Devries A; Nevinny-Stickel M; Saurer M; Lukas P; Seppi T
J Chemother; 2004 Aug; 16(4):372-80. PubMed ID: 15332713
[TBL] [Abstract][Full Text] [Related]
7. Taxane sensitivity of ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
[TBL] [Abstract][Full Text] [Related]
8. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
9. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of paclitaxel and docetaxel in human neuroblastoma cell lines.
Riccardi A; Servidei T; Tornesello A; Puggioni P; Mastrangelo S; Rumi C; Riccardi R
Eur J Cancer; 1995; 31A(4):494-9. PubMed ID: 7576952
[TBL] [Abstract][Full Text] [Related]
11. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
Untch M; Untch A; Sevin BU; Angioli R; Perras JP; Koechli O; Averette HE
Anticancer Drugs; 1994 Feb; 5(1):24-30. PubMed ID: 7910494
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant treatment with docetaxel and the effects of irradiation for human ovarian adenocarcinoma and cervical squamous cell carcinoma in vitro.
Araki S; Miyagi Y; Kawanishi K; Yamamoto J; Hongo A; Kodama J; Yoshinouchi M; Kudo T
Acta Med Okayama; 2002 Feb; 56(1):13-8. PubMed ID: 11873939
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies of Taxol as a radiation sensitizer in human tumor cells.
Liebmann J; Cook JA; Fisher J; Teague D; Mitchell JB
J Natl Cancer Inst; 1994 Mar; 86(6):441-6. PubMed ID: 7907149
[TBL] [Abstract][Full Text] [Related]
14. Survival of colorectal cancer cell lines treated with paclitaxel, radiation, and 5-FU: effect of TP53 or hMLH1 deficiency.
Kennedy AS; Harrison GH; Mansfield CM; Zhou XJ; Xu JF; Balcer-Kubiczek EK
Int J Cancer; 2000 Aug; 90(4):175-85. PubMed ID: 10993958
[TBL] [Abstract][Full Text] [Related]
15. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol).
Liebmann J; Cook JA; Fisher J; Teague D; Mitchell JB
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):559-64. PubMed ID: 7911794
[TBL] [Abstract][Full Text] [Related]
16. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
17. Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ).
Pradier O; Rave-Fränk M; Lehmann J; Lücke E; Boghun O; Hess CF; Schmidberger H
Int J Cancer; 2001 Mar; 91(6):840-5. PubMed ID: 11275989
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro.
Amorino GP; Hamilton VM; Choy H
Radiat Oncol Investig; 1999; 7(6):343-52. PubMed ID: 10644057
[TBL] [Abstract][Full Text] [Related]
19. Resistance of human multidrug-resistant neoplastic cell lines to paclitaxel-induced-radiosensitization is reduced by the non-immunosuppressive cyclosporine analog SDZ PSC 833.
Sedlak J; Hunakova L; Chorvath M; Sulikova M; Novotny L; Boljesikova E; Zeillinger R; Chorvath B
Anticancer Res; 1998; 18(4C):3099-105. PubMed ID: 9713517
[TBL] [Abstract][Full Text] [Related]
20. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
Vredenburg MR; Ojima I; Veith J; Pera P; Kee K; Cabral F; Sharma A; Kanter P; Greco WR; Bernacki RJ
J Natl Cancer Inst; 2001 Aug; 93(16):1234-45. PubMed ID: 11504769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
